| |
| |
|
| Insider
Information: |
Rivera Jose E |
| Relationship: |
EVP, General Counsel |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
162,388 |
|
|
Indirect Shares
|
262,210 |
|
|
| Direct
Value |
$3,972,010 |
|
|
|
Indirect Value
|
$6,413,657 |
|
|
| Total
Shares |
424,598 |
|
|
| Total
Value |
$10,385,667 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
1
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
1.0
|
| Percentage
Gain/Loss : |
0.0%
|
 154.5%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Intellia Therapeutics, Inc. |
NTLA |
EVP, General Counsel |
2021-04-01 |
162,388 |
2021-04-01 |
262,210 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| NTLA |
Intellia Therapeutics, In... |
EVP, General Counsel |
• – – |
2021-04-01 |
4 |
AS |
$80.73 |
$4,160,559 |
D/D |
(50,455) |
162,388 |
0 |
% |
|
| NTLA |
Intellia Therapeutics, In... |
EVP, General Counsel |
• – – |
2021-04-01 |
4 |
OE |
$6.83 |
$1,213,537 |
D/D |
97,001 |
178,077 |
0 |
- |
|
| NTLA |
Intellia Therapeutics, In... |
EVP, General Counsel |
• – – |
2021-02-09 |
4 |
AS |
$75.00 |
$861,675 |
D/D |
(11,489) |
117,920 |
0 |
% |
|
| NTLA |
Intellia Therapeutics, In... |
EVP, General Counsel |
• – – |
2021-02-09 |
4 |
OE |
$18.30 |
$384,195 |
D/D |
21,000 |
129,409 |
0 |
- |
|
| NTLA |
Intellia Therapeutics, In... |
EVP, General Counsel |
• – – |
2021-02-01 |
4 |
AS |
$63.31 |
$3,497,902 |
D/D |
(54,659) |
108,409 |
0 |
% |
|
| NTLA |
Intellia Therapeutics, In... |
EVP, General Counsel |
• – – |
2021-02-01 |
4 |
OE |
$6.83 |
$1,054,620 |
D/D |
109,000 |
113,876 |
0 |
- |
|
| NTLA |
Intellia Therapeutics, In... |
EVP, General Counsel |
• – – |
2021-01-05 |
4 |
S |
$55.86 |
$116,077 |
D/D |
(2,078) |
51,990 |
0 |
% |
|
| NTLA |
Intellia Therapeutics, In... |
EVP, General Counsel |
• – – |
2020-12-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,792 |
54,068 |
0 |
- |
|
| NTLA |
Intellia Therapeutics, In... |
EVP, General Counsel |
• – – |
2020-12-01 |
4 |
AS |
$37.73 |
$128,525 |
D/D |
(3,364) |
48,708 |
0 |
% |
|
| NTLA |
Intellia Therapeutics, In... |
EVP, General Counsel |
• – – |
2020-12-01 |
4 |
OE |
$13.88 |
$69,400 |
D/D |
5,000 |
52,072 |
0 |
- |
|
| NTLA |
Intellia Therapeutics, In... |
EVP, General Counsel |
• – – |
2020-11-18 |
4 |
AS |
$35.00 |
$21,840 |
D/D |
(624) |
47,072 |
0 |
% |
|
| NTLA |
Intellia Therapeutics, In... |
EVP, General Counsel |
• – – |
2020-11-18 |
4 |
OE |
$18.30 |
$15,518 |
D/D |
848 |
47,696 |
0 |
- |
|
| NTLA |
Intellia Therapeutics, In... |
EVP, General Counsel |
• – – |
2020-11-16 |
4 |
AS |
$33.75 |
$206,728 |
D/D |
(6,029) |
46,848 |
0 |
% |
|
| NTLA |
Intellia Therapeutics, In... |
EVP, General Counsel |
• – – |
2020-11-16 |
4 |
OE |
$6.83 |
$78,585 |
D/D |
10,562 |
47,262 |
0 |
- |
|
| NTLA |
Intellia Therapeutics, In... |
EVP, General Counsel |
• – – |
2020-11-04 |
4 |
AS |
$28.00 |
$94,192 |
D/D |
(3,364) |
42,315 |
0 |
% |
|
| NTLA |
Intellia Therapeutics, In... |
EVP, General Counsel |
• – – |
2020-11-04 |
4 |
OE |
$13.88 |
$69,400 |
D/D |
5,000 |
45,679 |
0 |
- |
|
| NTLA |
Intellia Therapeutics, In... |
EVP, General Counsel |
• – – |
2020-10-15 |
4 |
AS |
$24.19 |
$135,883 |
D/D |
(5,615) |
40,679 |
0 |
% |
|
| NTLA |
Intellia Therapeutics, In... |
EVP, General Counsel |
• – – |
2020-10-15 |
4 |
OE |
$6.83 |
$68,300 |
D/D |
10,000 |
46,294 |
0 |
- |
|
| NTLA |
Intellia Therapeutics, In... |
EVP, General Counsel |
• – – |
2020-09-15 |
4 |
AS |
$21.04 |
$118,140 |
D/D |
(5,615) |
36,294 |
0 |
% |
|
| NTLA |
Intellia Therapeutics, In... |
EVP, General Counsel |
• – – |
2020-09-15 |
4 |
OE |
$6.83 |
$68,300 |
D/D |
10,000 |
41,909 |
0 |
- |
|
| NTLA |
Intellia Therapeutics, In... |
EVP, General Counsel |
• – – |
2020-08-18 |
4 |
AS |
$21.00 |
$117,915 |
D/D |
(5,615) |
31,909 |
0 |
% |
|
| NTLA |
Intellia Therapeutics, In... |
EVP, General Counsel |
• – – |
2020-08-18 |
4 |
OE |
$6.83 |
$68,300 |
D/D |
10,000 |
37,524 |
0 |
- |
|
| NTLA |
Intellia Therapeutics, In... |
EVP, General Counsel |
• – – |
2020-07-15 |
4 |
OE |
$6.83 |
$68,300 |
D/D |
10,000 |
33,139 |
0 |
- |
|
| NTLA |
Intellia Therapeutics, In... |
EVP, General Counsel |
• – – |
2020-07-15 |
4 |
AS |
$22.70 |
$127,461 |
D/D |
(5,615) |
27,524 |
0 |
% |
|
| NTLA |
Intellia Therapeutics, In... |
EVP, General Counsel |
• – – |
2020-06-16 |
4 |
AS |
$21.00 |
$117,915 |
D/D |
(5,615) |
22,282 |
0 |
% |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
